Delivery Order SPE2DB22D3301-SPE2DB25FY9UC
- Not listed
- This federal contract award is a delivery order worth $2,210.44 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of the pharmaceutical product Nitrofurantoin MCR 100 mg capsules. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nitrofurantoin 25 mg/5 ml suspension in a 230 ml quantity, with a ceiling value of $6,907.65. This contract represents a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.09 to AmerisourceBergen Drug Corp for the supply of Nitrofurantoin Mono-MCR 100 mg tablets (100 count) on July 30, 2025, with completion scheduled for July 31, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract employs firm fixed-price pricing and is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $12,954.29 to provide nitrofurantoin mono-MCR 100 mg pharmaceutical products. This delivery order has a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to deliver a comprehensive range of pharmaceuticals and...
- The Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $19,431.42 for Nitrofurantoin 25 mg/5 mL suspension (230 mL) on August 5, 2025, with completion expected by August 6, 2025. This is a firm fixed-price, non-set-aside contract with performance occurring at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $15,539.37 firm fixed price delivery order is for the supply of 240 mL bottles of Nitrofurantoin 25 mg/5 mL suspension medication. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical through November 2026, which serves as a primary...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 100 milligram Nitrofurantoin Mono-MCR medication, with a ceiling value of $7,415.81 and a period of performance through May 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nitrofurantoin 25 mg/5 ml suspension with a ceiling value of $3,033.72. It is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $6,851.61 to Amerisourcebergen Drug Corporation for the supply of 240 milliliters of nitrofurantoin suspension at 25 milligrams per 5 milliliters. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning just one day from September 14 to September 15, 2023. The delivery order was issued against an...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $4,441.72 award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, with a period of performance through March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9UCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,083.53 to AmerisourceBergen Drug Corp for the supply of Nitrofurantoin MCR 100 mg capsules (100-count bottles). This competitive award, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, reflects a firm fixed-price transaction with no set-aside designation. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction typical of the company's extensive pharmaceutical supply portfolio for federal military and healthcare systems. This award is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves critical federal medical procurement needs, supplying generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains. The IDC enables the company to fulfill orders for military healthcare programs worldwide, supporting customers including the Defense Health Agency and the U.S. Coast Guard, positioning the company as a key vendor in the Department of Defense's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/21/25 |